Patents by Inventor David I. Shreiber

David I. Shreiber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11987777
    Abstract: Systems and methods for cell electroporation and molecular delivery using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells.
    Type: Grant
    Filed: January 7, 2021
    Date of Patent: May 21, 2024
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Jeffrey Zahn, Mingde Zheng, David I. Shreiber, Hao Lin, Jerry W. Shan
  • Patent number: 11639377
    Abstract: The disclosure discloses a preparation of type I collagen-like fibers and a method for regulating and controlling the periodic length of fiber stripes thereof, belonging to the technical field of genetic engineering. The disclosure produces a three-segment chimeric collagen P-CL-P pattern by inserting a continuous Gly-Xaa-Yaa triplet collagen sequence in the middle based on the N- and C-terminal (GPP)n sequences. The self-assembly is driven by the interaction between the N- and C-terminal (GPP)n triple helixes to form banded fibers with periodic bright and dark stripes. According to the method of the disclosure, a fiber from a clean source, which can self-assemble to form periodic bright and dark stripes can be prepared, the structure of which is similar to type I collagen, the preparation process is simple, the collagen fiber with low cost can be produced on a large scale, and the method has broad application prospects in the field of biological materials.
    Type: Grant
    Filed: October 28, 2020
    Date of Patent: May 2, 2023
    Assignees: JIANGNAN UNIVERSITY, RUTGERS UNIVERSITY
    Inventors: Fei Xu, Jinyuan Hu, Vikas Nanda, David I. Shreiber, Meng Zhang, Sonal Gahlawat
  • Publication number: 20210369864
    Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.
    Type: Application
    Filed: August 10, 2021
    Publication date: December 2, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
  • Publication number: 20210338571
    Abstract: A method and apparatus for promoting the delivery of a molecule across a cell membrane comprises delivering a molecule to a delivery site of a region of tissue surrounding the cell membrane. A suction component applies a suction through a suction tip that surrounds the surface of the delivery site creating a seal to promote delivery of the molecule across the cell membrane. The application of the suction is controlled to create a predetermined negative pressure for a predetermined period of time before releasing the negative pressure. Suction is used to enhance permeabilization and transfection of cells. The technique can be used to enhance the uptake and subsequent transfection and expression of plasmid DNA vaccines, mRNA vaccines and other nucleic acid molecules, that are introduced subcutaneously. It can be used in combination with coated microneedles.
    Type: Application
    Filed: May 3, 2021
    Publication date: November 4, 2021
    Inventors: Hao Lin, Jonathan P. Singer, David I. Shreiber, Jerry W. Shan, Jeffrey D. Zahn, Emran O. Lallow, Juliet M. Melnik, Nandita Chakrabarty Jhumur
  • Patent number: 11020491
    Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.
    Type: Grant
    Filed: June 14, 2018
    Date of Patent: June 1, 2021
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
  • Publication number: 20210139825
    Abstract: Systems and methods for cell electroporation and molecular delivery using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells.
    Type: Application
    Filed: January 7, 2021
    Publication date: May 13, 2021
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Jeffrey Zahn, Mingde Zheng, David I. Shreiber, Hao Lin, Jerry W. Shan
  • Publication number: 20210079064
    Abstract: The disclosure discloses a preparation of type I collagen-like fibers and a method for regulating and controlling the periodic length of fiber stripes thereof, belonging to the technical field of genetic engineering. The disclosure produces a three-segment chimeric collagen P-CL-P pattern by inserting a continuous Gly-Xaa-Yaa triplet collagen sequence in the middle based on the N- and C-terminal (GPP)n sequences. The self-assembly is driven by the interaction between the N- and C-terminal (GPP)n triple helixes to form banded fibers with periodic bright and dark stripes. According to the method of the disclosure, a fiber from a clean source, which can self-assemble to form periodic bright and dark stripes can be prepared, the structure of which is similar to type I collagen, the preparation process is simple, the collagen fiber with low cost can be produced on a large scale, and the method has broad application prospects in the field of biological materials.
    Type: Application
    Filed: October 28, 2020
    Publication date: March 18, 2021
    Inventors: Fei XU, Jinyuan HU, Vikas NANDA, David I. SHREIBER, Meng ZHANG, Sonal GAHLAWAT
  • Patent number: 10927333
    Abstract: Systems and methods for cell electroporation and molecular delivery using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells.
    Type: Grant
    Filed: September 2, 2016
    Date of Patent: February 23, 2021
    Assignee: RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY
    Inventors: Jeffrey Zahn, Mingde Zheng, David I. Shreiber, Hao Lin, Jerry W. Shan
  • Publication number: 20180360989
    Abstract: The present invention provides a biocompatible conjugate for treating a disease or an injury. The conjugate contains a polymer covalently linked to one or more moieties each containing a polymerizable functional group. The conjugate forms a cross-linked polymer network after being exposed to an elevated level of free radicals associated with the disease or injury.
    Type: Application
    Filed: June 14, 2018
    Publication date: December 20, 2018
    Applicant: Rutgers, The State University of New Jersey
    Inventors: Christopher Lowe, David I. Shreiber, Emily DiMartini, Adam Gormley
  • Publication number: 20180258379
    Abstract: Systems and methods for cell electroporation and molecular delivery using an intelligent, feedback controlled, microscale electroporation system for transfecting single cells.
    Type: Application
    Filed: September 2, 2016
    Publication date: September 13, 2018
    Inventors: Jeffrey Zahn, Mingde Zheng, David I. Shreiber, Hao Lin, Jerry W. Shan